16369-12-3 Purity
96%
If you have any other questions or need other size, please get a quote.
Specification
Amyloid β-derived diffusible ligands (ADDLs) serve as key contributors to the onset of initial cognitive impairments in Alzheimer's disease (AD). The study focused on understanding how L-stepholamine (L-SPD) affects cognitive abilities and synaptic plasticity in APP and PS1 double transgenic (APP/PS1) mice and hippocampal cultures or slices that received ADDL treatment. L-Stepholidine demonstrated dopamine D1-type receptor agonist effects while simultaneously serving as a D2-type receptor antagonist.
Potential Mechanisms of L-Stepholidine in Treating AD
· L-SPD has the potential to enhance hippocampus-dependent memory, increase the surface expression of AMPA receptors containing glutamate receptor A (GluA1), and improve spine density in the hippocampus of APP/PS1 transgenic mice. It not only counteracted reductions in GluA1 phosphorylation and surface expression in hippocampal cultures but also preserved long-term potentiation in hippocampal slices triggered by ADDLs.
· Similarly, the PKA agonist Sp-cAMPS and the D1-type receptor agonist SKF81297 produced comparable effects, while the PKA antagonist Rp-cAMPS and the D1-type receptor antagonist SCH23390 negated the influence of L-SPD on GluA1 trafficking. This effect is primarily mediated by PKA, which phosphorylates the serine residue at position 845 of GluA1.
· Thus, The D1/PKA signaling pathway activation by L-SPD improves AMPA receptor trafficking and synaptic plasticity which makes it a candidate therapeutic drug for AD.
L-Stepholidine (L-SPD) is a compound extracted from traditional Chinese medicine with potential for treating psychosis. The effects of L-SPD on executive function, working memory, and response inhibition, two core indicators of learning and memory, were studied here. This work confirmed that L-SPD can improve executive function, enhance memory, and upregulate the expression of glutamate receptors in PFC, providing clues for the treatment of psychotic cognitive dysfunction.
· Evaluation Methods
This work examined the effects of l-SPD on working memory through a delayed alternation T-maze task (DAT), assessed its influence on response inhibition via the stop-signal task (SST), and evaluated its impact on learning and memory through trace fear conditioning in Sprague-Dawley rats. Additionally, researchers assessed its effects on the expression of prefrontal glutamate receptors using western blot analysis.
· Evaluation Results
The rats treated with l-SPD showed a reduction in errors on the T-maze, increased speed in stopping their actions in response to the stop signal, and improved memory retention. Investigations into the underlying molecular mechanisms indicated that l-SPD enhances the expression of prefrontal glutamate receptors. Overall, these findings suggest that l-SPD enhances executive function and memory.
The molecular formula of l-Stepholidine is C19H21NO4.
Some synonyms for l-Stepholidine include stepholidine, (-)-Stepholidine, and (S)-3,9-Dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[3,2-a]isoquinoline-2,10-diol.
l-Stepholidine is a natural product found in Desmos cochinchinensis, Meiogyne monosperma, and other organisms.
The molecular weight of l-Stepholidine is 327.4 g/mol.
The IUPAC name of l-Stepholidine is (13aS)-3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,10-diol.
The InChI key of l-Stepholidine is JKPISQIIWUONPB-HNNXBMFYSA-N.
The canonical SMILES of l-Stepholidine is COC1=C(C=C2C3CC4=C(CN3CCC2=C1)C(=C(C=C4)O)OC)O.
The CAS number of l-Stepholidine is 16562-13-3.
The XLogP3-AA value of l-Stepholidine is 2.6.
Yes, l-Stepholidine is a canonicalized compound.